You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 26 No. 4, April 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Prediction of Response to Phenothiazines in Schizophrenia

A Crossvalidation Study

Solomon C. Goldberg, PhD; William A. Frosch, MD; Ann K. Drossman, BA; Nina R. Schooler, PhD; Gordon F. S. Johnson, MD

Arch Gen Psychiatry. 1972;26(4):367-373.


Abstract

Results of two earlier studies imply that schizophrenics could be assigned, according to their pattern of presenting symptomatology, to that phenothiazine on which they are likely to improve most. This paper reports an attempt to replicate these findings. The results are negative: prediction of better and worse drug assignment could not be made. Factors leading to our failure to predict as compared with successes in earlier work are discussed. The current "state of the art" in prediction of response to phenothiazines is equivocal; positive results in the literature preclude dismissing the idea totally, but are insufficient to establish the relationship as fact. For the practicing clinician no system is yet available, either from empirical research or accumulated clinical experience, to enable matching of particular phenothiazines with particular schizophrenic patients in terms of their symptom profiles.



Author Affiliations

Rockville, Md; New York; Rockville, Md; New York

From the Department of Psychiatry, New York University Medical Center (Dr. Frosch, A.K. Drossman, and Dr. Johnson) and the Psychopharmacology Research Branch, National Institute of Mental Health (Drs. Goldberg and Schooler).


Footnotes

Accepted for publication Sept 16, 1971.

Reprint requests to the Psychopharmacology Research Branch, NIMH, 5600 Fishers Lane, Rockville, Md 20852 (Dr. Goldberg).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Schizophrenia
Kane
NEJM 1996;334:34-42.
FULL TEXT  

A Comparison of Psychiatric and Psychological Assessments of Acute Schizophrenics
Burdock et al.
Applied Psychological Measurement 1978;2:175-187.
ABSTRACT  

Subjective Response as a Predictor of Outcome in Pharmacotherapy: The Consumer Has a Point
Van Putten and May
Arch Gen Psychiatry 1978;35:477-480.
ABSTRACT  

Specific Indications for Different Classes of Phenothiazines
Hollister et al.
Arch Gen Psychiatry 1974;30:94-99.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.